Clinical Trials Webinars

Search for upcoming webinars for Clinical Trials

Previous Webinars

Healthcare > Clinical Trials webinar by Cerba Research for Advancing CAR T-Cell Therapies with Clinical Trial Customization
Advancing CAR T-Cell Therapies with Clinical Trial Customization
Bringing together best practices in genomics, flow cytometry, biomarkers and clinical trial operations for successful CAR T-cell therapy clinical trials. This webinar emphasizes the challenges encountered and the importance of customized solutions in genomics, flow cytometry, biomarkers and clinical trial operations for successful CAR T-cell therapy clinical trials. The expert speakers will showcase the criticality of early engagement through two case studies, demonstrating how it allows for the design of tailored trials. They will then share best practices for overcoming challenges related to (1) monitoring CAR T-cells, (2) patient safety assurance and (3) assessment of therapy response. Join Cerba Research’s webinar to learn more about customized solutions for successful CAR T-cell therapy clinical trials and stay tuned for subsequent webinars and podcasts on their other CGT solutions.
4/15/2024 2:00 PM
Healthcare > Clinical Trials webinar by ESPNIC - European Society of Paediatric and Neonatal Intensive Care for ESPNIC Webinar - Optimizing Care for Persistent Pulmonary Hypertension of the Newborn (PPHN): Perspectives from a Neonatologist and a Cardiologist
ESPNIC Webinar - Optimizing Care for Persistent Pulmonary Hypertension of the Newborn (PPHN): Perspectives from a Neonatologist and a Cardiologist
This webinar aims to enhance understanding of Persistent Pulmonary Hypertension of the Newborn (PPHN), including its underlying physiology, diagnosis, and management, while emphasizing the collaborative efforts between neonatologists, paediatric intensivists and cardiologists to optimize patient care and outcomes. Our neonatologist speaker, Prof. Manuel Sánchez Luna, will discuss the importance of early recognition and therapeutic intervention in managing PPHN and key therapeutic strategies to improve outcomes and prevent mortality in the extremely severe cases. In addition, Prof. Sánchez Luna will address the utilization of non-invasive monitoring techniques, including pre- and post-ductal oxygen saturation, volumetric capnometry, and heart ultrasound, to identify PPHN and monitor response to specific therapies. By joining this session, you will also get insights from our cardiologist speaker, Prof. Maurice Beghetti, on the potential cardiac causes that may mimic PPHN in neonates and the importance of differentiating between cardiac and lung disease-induced pulmonary hypertension for appropriate treatment selection. Prof. Beghetti will also highlight different etiologies of PPHN and emphasize the importance of excluding cardiac lesions responsible for PPHN-like presentation. Target audience of this webinar: ICU Doctors in training – PICU, NICU and CICU; Cardiology doctors in training, ICU nurses, ECMO specialists, and other Allied Health Professionals. *This webinar is supported by an unrestricted educational grant from Masimo.
Healthcare > Clinical Trials webinar by OAE Publishing Inc. for The Journal of Cardiovascular Aging Webinar Series: Stem Cell & Genomics: From Precision Medicine to Clinical Trial in Dish
The Journal of Cardiovascular Aging Webinar Series: Stem Cell & Genomics: From Precision Medicine to Clinical Trial in Dish
Join The Journal of Cardiovascular Aging for a webinar featuring Sanjiv Sam Gambhir, M.D., Ph.D. as he lectures on Stem Cell & Genomics: From Precision Medicine to Clinical Trial in Dish Time. The webinar will take place on April 8, 2024, at 9:00 AM (New York time, UTC-4).
4/8/2024 2:00 PM
Healthcare > Clinical Trials webinar by Genetic Engineering and Biotechnology News for How AI-Supported Spatial Analysis and Multiplex Assays Elucidate the Tumor Microenvironment
How AI-Supported Spatial Analysis and Multiplex Assays Elucidate the Tumor Microenvironment
The tumor microenvironment is a complex mix of cancer cells, immune cells, and other components that all play a part in tumor progression, metastasis, and therapy responses. Understanding the highly dynamic nature of the tumor microenvironment and the factors that influence those changes is essential for developing effective precision oncology therapies. Innovations in computational pathology and artificial intelligence, coupled with novel multiplex biomarker assays, are critical to fostering that understanding. Together, they are paving the way for scientists to better characterize the unique cancer cell populations, spatial relationships, and differences in immune responses in the tumor microenvironment.In this GEN webinar, Michael Downing, Senior Image Analysis Scientist at Ultivue, will review the state of the field and introduce Ultivue’s two core platform technologies: InSituPlex® assays, and its proprietary Spatial Image Analysis pipeline featuring UltiStacker.AI™ and UltiAnalyzer.AI™. He will also explain how these technologies work together to provide high confidence insights from tumor data for scientists developing precision cancer therapies.Topics covered in the webinar will include:How AI-supported spatial image analysis together with Ultivue’s InSituPlex assays deliver accurate and scalable insights into the biology of the tumor microenvironment.How Ultivue’s 12-plex assay verification demonstrates its readiness to provide a comprehensive view of the tumor microenvironment.A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelist.
Healthcare > Clinical Trials webinar by Manatt, Phelps & Phillips, LLP for [Webinar] Bridging Public Health and Managed Care: A Collaborative Approach to Community Health Assessments - March 21st, 1:00 pm - 2:00 pm ET
[Webinar] Bridging Public Health and Managed Care: A Collaborative Approach to Community Health Assessments - March 21st, 1:00 pm - 2:00 pm ET
In the United States, public health and health care delivery have largely taken different and siloed approaches, with health care focused on the treatment of individuals and public health centered on the total population within a geographic region. Collaboration between the sectors is essential to advancing both health outcomes and equity—a lesson driven home during the COVID-19 pandemic. In a new webinar, Manatt Health will provide an in-depth look at the innovative ways California health agencies are working together to bridge the gap between public health and managed care health care delivery—and what other states can learn from the California model.
3/21/2024 1:00 PM
Healthcare > Clinical Trials webinar by Xtalks for Top Clinical Trial Supply Trends of 2024 and How to Meet and Exceed Them
Top Clinical Trial Supply Trends of 2024 and How to Meet and Exceed Them
As the life sciences industry continues to evolve rapidly, clinical research organizations (CROs) and trial sites are facing new challenges and opportunities in 2024. This webinar is designed to provide industry leaders with a deep dive into the most critical clinical trial supply trends and the strategies needed to navigate these effectively.
by Xtalks
3/13/2024 12:00 PM
Healthcare > Clinical Trials webinar by APM Education Hub for Palliative Care Research: Why it matters, and why you should do it
Palliative Care Research: Why it matters, and why you should do it
A webinar organised by the APM Juniors’ Committee. Date: Tuesday 27 February 2024 Time: 18:00 – 19:30 Speakers: Professor Fliss Murtagh and Dr Donna Wakefield. Learning Objectives: 1) Why bother with research in palliative care, including benefits and challenges 2) Hot topics in palliative care research 3) How to progress from an idea to implementing change, and how to get involved in each level. This event is FREE to attend. Ticket holders will be sent the recording after the session. Please book your place to ensure you are on the mailing list for the joining link and the recording. The joining link will be emailed to you via the email you have registered your place with the day before the event takes place. Please remember to check your Junk Mail folders in case the invite has fallen in there. To avoid our emails falling into junk folders please make sure your IT department ‘safelist’ the following email addresses kate@munrosmith.co.uk | becki@munrosmith.co.uk. It has been noted that some email accounts are viewable in plain text only. With this in mind, we will provide the meeting ID and passcode to your joining instructions to avoid any issues with broken links.
2/27/2024 6:00 PM
Healthcare > Clinical Trials webinar by Xtalks for Fry Shortening Reduction Innovation and Bakery Savings
Fry Shortening Reduction Innovation and Bakery Savings
This webinar pertains to fry shortening reduction, and how it impacts the bakery sector's savings. A significant focus will be given to food ingredients and innovations, along with food sustainability and environment.
by Xtalks
2/26/2024 5:00 PM
Healthcare > Clinical Trials webinar by CRIO for Navigating the Regulatory Landscape in Clinical Trials in 2024
Navigating the Regulatory Landscape in Clinical Trials in 2024
Staying current with regulatory changes is important when it comes to staying out of trouble with regulatory agencies, maintaining your reputation, and successfully conducting clinical trials. Join Marc Wartenberger, Director Corporate QA & Compliance at CRIO, for a review of new regulations, guidance, and decisions from 2023 that will impact clinical research.
by CRIO
2/21/2024 4:00 PM
Healthcare > Clinical Trials webinar by Caidya for Strategic Implications of Oncology Clinical Trial Design in Early-Phase Studies
Strategic Implications of Oncology Clinical Trial Design in Early-Phase Studies
Discover an informative webinar delving into how strategic oncology clinical trial design shapes success in early oncology studies using novel approaches. Trial design in early-phase oncology studies has a critical impact on the success of the study. Novel approaches such as biomarker stratification, adaptive enrichment designs, outcome-adaptive randomization and the integration of real-world data have been developed. In addition, under Project Optimus, dose expansion requires the selection of the most appropriate dose and schedule to be brought into the registrational trial, which also needs to be accomplished via dose-finding studies in early-phase trials. Attendees will learn insights into the trade-offs between protocol design options and offer insight into developing a trial structure that maximizes the chances of success in later phases of research while minimizing risk. Join this webinar to explore the intricate world of oncology trial design and gain valuable insights to enhance research approaches.
by Caidya
2/16/2024 4:00 PM
 

page 1 of 4

;